Shan Miao , Rui Zhang , Guiping Guo , Xinshang Wang , Bin Zhang , Long Li , Jin Wang , Yan Weng , Xiaopeng Shi , Shanbo Ma , Chenxi Lu
{"title":"P38蛋白作为败血症诱导的器官功能障碍的治疗靶点","authors":"Shan Miao , Rui Zhang , Guiping Guo , Xinshang Wang , Bin Zhang , Long Li , Jin Wang , Yan Weng , Xiaopeng Shi , Shanbo Ma , Chenxi Lu","doi":"10.1016/j.ejphar.2025.177833","DOIUrl":null,"url":null,"abstract":"<div><div>Sepsis is a systemic disorder with a dysregulated host response caused by infection and is associated with multiple organ dysfunction and a high risk of mortality. Several factors are involved in the complex pathophysiological process of sepsis, including the inflammatory response, immune response, mitochondrial dysfunction, and coagulation cascade. p38 proteins, a class of mitogen-activated protein kinases, play key roles in inflammatory/immune responses and are involved in essential cellular processes. Previous studies have shown that p38 is highly expressed in sepsis and sepsis-induced organ damage and is involved in complex biological, signaling-driven processes. Therefore, this review aims to summarize the efficacy and mechanism of action of p38 in treating sepsis and sepsis-induced multiple-organ damage. First, the basic structure, signal transduction mechanism of p38, and its role in the pathological process of sepsis are comprehensively described. Second, the mechanism of p38 in sepsis-induced multiple-organ damage (including the heart, liver, lung, and brain) is described. Finally, the discovery and application of p38 inhibitors and the role of p38 in sepsis is discussed. This review provides a new therapeutic target for sepsis-induced multiple-organ dysfunction.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"1002 ","pages":"Article 177833"},"PeriodicalIF":4.2000,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"p38 protein as a therapeutic target for sepsis-induced organ dysfunction\",\"authors\":\"Shan Miao , Rui Zhang , Guiping Guo , Xinshang Wang , Bin Zhang , Long Li , Jin Wang , Yan Weng , Xiaopeng Shi , Shanbo Ma , Chenxi Lu\",\"doi\":\"10.1016/j.ejphar.2025.177833\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Sepsis is a systemic disorder with a dysregulated host response caused by infection and is associated with multiple organ dysfunction and a high risk of mortality. Several factors are involved in the complex pathophysiological process of sepsis, including the inflammatory response, immune response, mitochondrial dysfunction, and coagulation cascade. p38 proteins, a class of mitogen-activated protein kinases, play key roles in inflammatory/immune responses and are involved in essential cellular processes. Previous studies have shown that p38 is highly expressed in sepsis and sepsis-induced organ damage and is involved in complex biological, signaling-driven processes. Therefore, this review aims to summarize the efficacy and mechanism of action of p38 in treating sepsis and sepsis-induced multiple-organ damage. First, the basic structure, signal transduction mechanism of p38, and its role in the pathological process of sepsis are comprehensively described. Second, the mechanism of p38 in sepsis-induced multiple-organ damage (including the heart, liver, lung, and brain) is described. Finally, the discovery and application of p38 inhibitors and the role of p38 in sepsis is discussed. This review provides a new therapeutic target for sepsis-induced multiple-organ dysfunction.</div></div>\",\"PeriodicalId\":12004,\"journal\":{\"name\":\"European journal of pharmacology\",\"volume\":\"1002 \",\"pages\":\"Article 177833\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-06-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0014299925005874\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014299925005874","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
p38 protein as a therapeutic target for sepsis-induced organ dysfunction
Sepsis is a systemic disorder with a dysregulated host response caused by infection and is associated with multiple organ dysfunction and a high risk of mortality. Several factors are involved in the complex pathophysiological process of sepsis, including the inflammatory response, immune response, mitochondrial dysfunction, and coagulation cascade. p38 proteins, a class of mitogen-activated protein kinases, play key roles in inflammatory/immune responses and are involved in essential cellular processes. Previous studies have shown that p38 is highly expressed in sepsis and sepsis-induced organ damage and is involved in complex biological, signaling-driven processes. Therefore, this review aims to summarize the efficacy and mechanism of action of p38 in treating sepsis and sepsis-induced multiple-organ damage. First, the basic structure, signal transduction mechanism of p38, and its role in the pathological process of sepsis are comprehensively described. Second, the mechanism of p38 in sepsis-induced multiple-organ damage (including the heart, liver, lung, and brain) is described. Finally, the discovery and application of p38 inhibitors and the role of p38 in sepsis is discussed. This review provides a new therapeutic target for sepsis-induced multiple-organ dysfunction.
期刊介绍:
The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.
The scope includes:
Behavioural pharmacology
Neuropharmacology and analgesia
Cardiovascular pharmacology
Pulmonary, gastrointestinal and urogenital pharmacology
Endocrine pharmacology
Immunopharmacology and inflammation
Molecular and cellular pharmacology
Regenerative pharmacology
Biologicals and biotherapeutics
Translational pharmacology
Nutriceutical pharmacology.